NM_001144013.2:c.5128G>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144013.2(RGPD3):c.5128G>A(p.Val1710Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000192 in 1,611,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 29 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251084 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000199 AC: 29AN: 1459700Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 18AN XY: 726154 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152192Hom.: 0 Cov.: 29 AF XY: 0.0000134 AC XY: 1AN XY: 74350 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5128G>A (p.V1710M) alteration is located in exon 22 (coding exon 22) of the RGPD3 gene. This alteration results from a G to A substitution at nucleotide position 5128, causing the valine (V) at amino acid position 1710 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at